Wei-Bo Dai (Weibo Dai)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Inflammatory Response

Top Venues

Oxidative medicine and cellular longevity

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyi Zhan, Weijie Peng, Zhuqiang Wang, Xin Liu, Wei-Bo Dai, Quan-Xi Mei, Xianjing Hu
Polysaccharides from Garlic Protect against Liver Injury in DSS-Induced Inflammatory Bowel Disease of Mice via Suppressing Pyroptosis and Oxidative Damage. Oxidative medicine and cellular longevity 2022 (2022)
Leyu Li, Guoxin Huang, Tingbo Chen, Hui Lin, Ruiyan Xu, Jinyan Cheng, Ying Hu, Wei-Bo Dai, Gengting Dong
Fufang Fanshiliu Decoction Revealed the Antidiabetic Effect through Modulating Inflammatory Response and Gut Microbiota Composition. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Wei-Bo Dai, Xinyi Zhan, Weijie Peng, Xin Liu, Weiwen Peng, Quanxi Mei, Xianjing Hu
Ficus pandurata Hance Inhibits Ulcerative Colitis and Colitis-Associated Secondary Liver Damage of Mice by Enhancing Antioxidation Activity. Oxidative medicine and cellular longevity 2021 (2021)
Dan Su, Yu-Qiao Gao, Wei-Bo Dai, Ying Hu, Yan-Fen Wu, Quan-Xi Mei
Helicteric Acid, Oleanic Acid, and Betulinic Acid, Three Triterpenes from Helicteres angustifolia L., Inhibit Proliferation and Induce Apoptosis in HT-29 Colorectal Cancer Cells via Suppressing NF-κB and STAT3 Signaling. Evidence-based complementary and alternative medicine : eCAM 2017 (2017)